196
Participants
Start Date
October 31, 2006
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Tranexamic acid tablets
3900 mg/Day
Placebo tablets
Investigative Site, Abington
Investigative Site, Jenkintown
Investigative Site, Reading
Investigative Site, Charleston
Investigative Site, Huntington
Investigative Site, Columbia
Investigative Site, Charleston
Investigative Site, Greenville
Investigative Site, Greer
Investigative Site, Decatur
Investigative Site, Atlanta
Investigative Site, Atlanta
Investigative Site, Savannah
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Inverness
Investigative Site, Chattanooga
Investigative Site, Knoxville
Investigative Site, Memphis
Investigative Site, Zanesville
Investigative Site, Cleveland
Investigative Site, Canfield
Investigative Site, Centerville
Investigative Site, Paw Paw
Investigative Site, Menomonee Falls
Investigative Site, Scottsbluff
Investigative Site, Marrero
Investigative Site, Amite
Investigative Site, Baton Rouge
Investigative Site, Shreveport
Investigative Site, Little Rock
Investigative Site, Norman
Investigative Site, Oklahoma City
Investigative Site, Dallas
Investigative Site, Houston
Investigative Site, Denver
Investigative Site, Lakewood
Investigative Site, Idaho Falls
Investigative Site, Sandy City
Investigative Site, Tucson
Investigative Site, Tucson
Investigative Site, Upland
Investigative Site, San Diego
Investigative Site, Carmichael
Investigative Site, Portland
Investigative Site, Salem
Investigative Site, Eugene
Investigative Site, Medford
Investigative Site, Spokane
Investigative Site, Groton
Investigative Site, West Hartford
Investigative Site, Lawrenceville
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY